Cargando…
In vitro additive antitumor effects of dimethoxycurcumin and 5‐fluorouracil in colon cancer cells
Dimethoxycurcumin (DMC) is a lipophilic analog of curcumin, an effective treatment for colon cancer, which has greater chemical and metabolic stability. Chemotherapy treatments, such as 5‐fluorouracil (5‐Fu), play a key role in the current management of colon cancer. In this study, we investigated t...
Autores principales: | Zhao, Huiying, Liu, Qingchun, Wang, Saisai, Dai, Fang, Cheng, Xiaofei, Cheng, Xiaobin, Chen, Wenbin, Zhang, Min, Chen, Dong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5504307/ https://www.ncbi.nlm.nih.gov/pubmed/28573788 http://dx.doi.org/10.1002/cam4.1114 |
Ejemplares similares
-
In Vitro and in Vivo antitumor activity and the mechanism of siphonodictyal B in human colon cancer cells
por: Chikamatsu, Sonoko, et al.
Publicado: (2019) -
MicroRNA‐21 induces 5‐fluorouracil resistance in human pancreatic cancer cells by regulating PTEN and PDCD4
por: Wei, Xueju, et al.
Publicado: (2016) -
Complex polymeric nanomicelles co-delivering doxorubicin and dimethoxycurcumin for cancer chemotherapy
por: Sohail, Muhammad, et al.
Publicado: (2022) -
BMI1 is downregulated by the natural compound curcumin, but not by bisdemethoxycurcumin and dimethoxycurcumin
por: Adeyeni, Temitope A., et al.
Publicado: (2016) -
A novel monoclonal antibody KMP1 has potential antitumor activity of bladder cancer by blocking CD44 in vivo and in vitro
por: Chen, Yujin, et al.
Publicado: (2018)